CVS HEALTH CORPORATION (CVS) FY2024 YTD Q3 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

275,099,000,000 US dollars

Total operating costs

268,951,000,000 US dollars

Operating income

6,148,000,000 US dollars

Other income (expense), net (calculated)

negative 2,126,000,000 US dollars

Income before income tax provision

4,022,000,000 US dollars

Income tax provision

1,059,000,000 US dollars

Net income

2,963,000,000 US dollars

Health Care Benefits

97,707,000,000 US dollars

Health Services

126,585,000,000 US dollars

Pharmacy & Consumer Wellness

90,986,000,000 US dollars

Cost of products sold

151,019,000,000 US dollars

Health care costs

85,578,000,000 US dollars

Operating expenses

31,185,000,000 US dollars

Restructuring charges

1,169,000,000 US dollars

Loss on assets held for sale

0 US dollars

Revenue before reconciliation (calculated)

315,278,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Intersegment Eliminations

negative 40,547,000,000 US dollars. Reported reconciliation to consolidated revenue.

Corporate/ Other

368,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to CVS HEALTH CORPORATION: $2.97 B; to noncontrolling interests: −$7.00 M.